Gembruch U, Baschat A A, Gloeckner-Hoffmann K, Gortner L, Germer U
Department of Obstetrics and Gynecology, Medical University, Lübeck, Germany.
Ultrasound Obstet Gynecol. 2002 May;19(5):454-60. doi: 10.1046/j.1469-0705.2002.00689.x.
To study the relationship between prenatal appearance and perinatal outcome of fetuses with hepatic hemangiomata with special emphasis on criteria that may help to improve perinatal management.
In a tertiary referral center six fetuses with hepatic hemangiomata were evaluated by gray-scale, color, and pulsed wave Doppler ultrasound between 1994 and 2000. Fetal blood sampling was performed in four cases. All data (computerized files and video tapes) were analyzed retrospectively.
Two fetuses showed very similar sonographic findings. They had an isolated large ('giant') round hepatic hemangioma (diameter 43 and 68 mm, respectively) supplied by one hepatic artery and drained by one hepatic vein, both of them showing high velocity and low pulsatility blood flow. Fetal blood count and coagulation parameters were normal in one case, whereas the other fetus showed a Kasabach-Merritt sequence with severe thrombocytopenia (10 platelets/nL) and mild disseminated intravascular coagulation. Intrauterine platelet transfusion was performed immediately prior to planned Cesarean delivery. Rapid platelet consumption continued postnatally, requiring several thrombocyte transfusions. Platelet counts stabilized only after tumor resection on the second day of life. One fetus with diffuse neonatal hemangiomatosis developed high-output cardiac failure with hydrops in addition to Kasabach-Merritt sequence (15 platelets/nL), and died following premature delivery. Three fetuses, however, showing an isolated small hyperechogenic hepatic hemangioma (5, 5, and 6 mm in diameter, respectively) did not develop any perinatal complications.
Large fetal liver hemangiomata and diffuse hemangiomatosis may cause severe perinatal complications, particularly high-output cardiac failure and/or Kasabach-Merritt sequence with severe consumption of platelets and clotting factors and hemolytic anemia. Fetal blood sampling enables the prenatal detection of these potential complications, allowing critical modification of perinatal management such as intrauterine platelet transfusion, especially directly before delivery. In contrast, isolated small hyperreflexic hepatic hemangiomata do not appear to be associated with any of these fetal and postnatal sequelae.
研究肝血管瘤胎儿的产前表现与围产期结局之间的关系,特别强调有助于改善围产期管理的标准。
在一家三级转诊中心,于1994年至2000年间,对6例肝血管瘤胎儿进行了灰阶、彩色及脉冲波多普勒超声评估。4例进行了胎儿血样采集。所有数据(计算机文件和录像带)均进行回顾性分析。
2例胎儿显示出非常相似的超声检查结果。他们有孤立的大(“巨大”)圆形肝血管瘤(直径分别为43和68毫米),由一条肝动脉供血,一条肝静脉引流,二者均显示高速和低搏动性血流。1例胎儿的血细胞计数和凝血参数正常,而另1例胎儿出现卡萨巴赫-梅里特综合征,伴有严重血小板减少(10个血小板/微升)和轻度弥散性血管内凝血。在计划剖宫产分娩前立即进行了宫内血小板输注。产后血小板快速消耗仍在继续,需要多次输注血小板。仅在出生第二天肿瘤切除后血小板计数才稳定下来。1例患有弥漫性新生儿血管瘤病的胎儿除卡萨巴赫-梅里特综合征(15个血小板/微升)外还发生了高输出量心力衰竭并伴有水肿,早产之后死亡。然而,3例分别显示孤立的小的高回声肝血管瘤(直径分别为5、5和6毫米)的胎儿未发生任何围产期并发症。
大的胎儿肝血管瘤和弥漫性血管瘤病可能导致严重的围产期并发症,特别是高输出量心力衰竭和/或卡萨巴赫-梅里特综合征,伴有血小板和凝血因子的严重消耗以及溶血性贫血。胎儿血样采集能够在产前检测出这些潜在并发症,从而对围产期管理进行关键调整,如宫内血小板输注,尤其是在分娩前直接进行。相比之下,孤立的小的高反射性肝血管瘤似乎与这些胎儿期及出生后后遗症均无关联。